Opexa Therapeutics (OPXA) Misses Q3 EPS by 3c
Get Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) reported Q3 EPS of ($0.28), $0.03 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $726.3 thousand versus the consensus estimate of $720 thousand.
Cash and cash equivalents were $5,814,300 as of September 30, 2016, compared to $12,583,764 as of December 31, 2015. As of September 30, 2016, the Company had accounts payable and accrued expenses of $2,121,043.
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
- Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
- Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!